Cited by 335Neuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson’s disease

Open access
Pott Godoy, M. C., Tarelli, R., Ferrari, C. C., Sarchi, M. I., Pitossi, F. J.·2008·Brain

Abstract

Parkinson's disease is a neurodegenerative disorder with uncertain aetiology and ill-defined pathophysiology. Activated microglial cells in the substantia nigra (SN) are found in all animal models of Parkinson's disease and patients with the illness. Microglia may, however, have detrimental and protective functions in this disease. In this study, we tested the hypothesis that a sub-toxic dose of an inflammogen (lipopolysaccharide) can shift microglia to a pro-inflammatory state and exacerbate disease progression in an animal model of Parkinson's disease. Central lipopolysaccharide injection in a degenerating SN exacerbated neurodegeneration, accelerated and increased motor signs and shifted microglial activation towards a pro-inflammatory phenotype with increased interleukin-1beta (IL-1beta) secretion. Glucocorticoid treatment and specific IL-1 inhibition reversed these effects. Importantly, chronic systemic expression of IL-1 also exacerbated neurodegeneration and microglial activation in the SN. In vitro, IL-1 directly exacerbated 6-OHDA-triggered dopaminergic toxicity. In vivo, we found that nitric oxide was a downstream molecule of IL-1 action and partially responsible for the exacerbation of neurodegeneration observed. Thus, IL-1 exerts its exacerbating effect on degenerating dopaminergic neurons by direct and indirect mechanisms. This work demonstrates an unequivocal association between IL-1 overproduction and increased disease progression, pointing to inflammation as a risk factor for Parkinson's disease and suggesting that inflammation should be efficiently handled in patients to slow disease progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awn101

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a different PD mouse model, blocking IL-1β signaling using an IL-1 receptor antagonist significantly attenuated neurodegeneration.

    “In a different PD mouse model, blocking IL-1β signaling using an IL-1 receptor antagonist also significantly attenuated neurodegeneration.362,363”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [363]

    The Results section (Fig. 5A; page not provided) reports that IL-1 receptor antagonist treatment significantly preserved dopaminergic neurons in the 6-OHDA/LPS model. However, the Fig. 1 description identifies the animals in that experiment as rats, not mice. (LLM, conf=0.93)

    Experimental — accuracy not yet measured
  • Studies on experimental PD models argue that dopamine neurons are very susceptible to both oxidative stress and inflammation.

    “Studies on experimental PD models argue that dopamine neurons are very susceptible to both oxidative stress and inflammation [121,122],”

    From Beneficial Effects of Spirulina Consumption on Brain Health (2022) · cites this paper as [122]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Pott Godoy, M. C., Tarelli, R., Ferrari, C. C., Sarchi, M. I., & Pitossi, F. J.
Affiliations
Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
Corresponding author
Pitossi, F. J.
Venue
Brain
Published
2008-05-26
Volume
131
Issue
7
Pages
1880-1894
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2149298826
Cited by
335
References
53
Citations by year
2026: 5 · 2025: 12 · 2024: 14 · 2023: 18 · 2022: 17 · 2021: 24 · 2020: 20 · 2019: 18 · 2018: 19 · 2017: 23 · 2016: 12 · 2015: 22 · 2014: 23 · 2013: 19 · 2012: 21
FWCI
14.88
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Brain (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Americanae (AECID Library) (submittedVersion, cc-by-nc)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc)
Funders
  • Michael J. Fox Foundation for Parkinson's Research
  • Consejo Nacional de Investigaciones Científicas y Técnicas
  • Fundación YPF
  • Agencia Nacional de Promoción Científica y Tecnológica (CONICET)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
Keywords
Parkinson's disease, IL-1β, neuroinflammation, microglial activation, substantia nigra, lipopolysaccharide, dopaminergic neuron loss, 6-hydroxydopamine, nitric oxide, glucocorticoid therapy, IL-1 inhibition, motor symptoms, neurodegeneration
MeSH terms
Animals, Cells, Cultured, Dexamethasone, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Glucocorticoids, Interleukin-1, Lipopolysaccharides, Male, Nerve Degeneration, Nitric Oxide, Parkinson Disease, Psychomotor Performance, Substantia Nigra, Oxidopamine, Rats, Wistar, Microglia, Disease Progression, Reverse Transcriptase Polymerase Chain Reaction, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review